Key points from article :
Several biotech startups are helping to advance refinement, manufacturability of stem cells.
1. Celularity, a spinoff from Celgene, is developing allogeneic placenta-derived cell therapy in the areas of hematology, infectious disease, and degenerative disease.
Placenta-derived stem cells can be delivered allogeneically without the need to match the donor to the recipient.
2. ReNeuron, a company that develops vision restoration therapy from stem cells.
It has a program for retinitis pigmentosa (RP) that is in Phase I/IIa.
3. Glycostem is the world’s first completely closed manufacturing cleanroom.
4. Mogrify uses a stemness without stem cells to convert any human cell type into any other.
5. Magenta Therapeutics is a stem cell biology platform company focused on patient preparation, stem cell collection and dosing, and safe immune regeneration.
6. Cell Guidance Systems and Northwestern University develops stem cell therapies for sensorineural hearing loss.
